2,4-dimethyl (2R,4R)-1-benzylazetidine-2,4-dicarboxylate

Catalog No. :
ACDVIG727
CAS No. :
1807933-83-0
Molecular Formula :
C14H17NO4
Molecular Weight :
263.29

IUPAC Name:dimethyl (2R,4R)-1-benzylazetidine-2,4-dicarboxylate

2,4-dimethyl (2R,4R)-1-benzylazetidine-2,4-dicarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$463.00Login to see priceInquiryInquiry
250mg98%$775.00Login to see priceInquiryInquiry
1g98%$1547.00Login to see priceInquiryInquiry
5g98%$3281.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,4-dimethyl (2R,4R)-1-benzylazetidine-2,4-dicarboxylate
IUPAC Namedimethyl (2R,4R)-1-benzylazetidine-2,4-dicarboxylate
MDL No.MFCD28063993
Molecular FormulaC14H17NO4
Molecular Weight263.29
SMILESO=C([C@@H]1N(CC2=CC=CC=C2)[C@@H](C(OC)=O)C1)OC
InChI KeyCOJVYCMOVXNWAM-VXGBXAGGSA-N
Synonym2,4-dimethyl (2R,4R)-1-benzylazetidine-2,4-dicarboxylate;2,4-Azetidinedicarboxylic acid, 1-(phenylmethyl)-, 2,4-dimethyl ester, (2R,4R)-;dimethyl (2r,4r)-1-benzylazetidine-2,4-dicarboxylate
CAS No.1807933-83-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACDVIG727 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDVIG727 route product structure diagram
    ACDVIG7271807933-83-0
Inquiry

2. ACDVIG727 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDVIG727 route product structure diagram
    ACDVIG7271807933-83-0
Inquiry

Comments (0)